Page last updated: 2024-10-25

ciclopirox and Stomach Neoplasms

ciclopirox has been researched along with Stomach Neoplasms in 1 studies

Stomach Neoplasms: Tumors or cancer of the STOMACH.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Chen, L3
Chen, D3
Li, J3
He, L3
Chen, T3
Song, D3
Shan, S3
Wang, J3
Lu, X3
Lu, B3

Other Studies

1 other study available for ciclopirox and Stomach Neoplasms

ArticleYear
Ciclopirox drives growth arrest and autophagic cell death through STAT3 in gastric cancer cells.
    Cell death & disease, 2022, 11-28, Volume: 13, Issue:11

    Topics: Autophagic Cell Death; Ciclopirox; Humans; Phosphorylation; Serine; STAT3 Transcription Factor; Stom

2022
Ciclopirox drives growth arrest and autophagic cell death through STAT3 in gastric cancer cells.
    Cell death & disease, 2022, 11-28, Volume: 13, Issue:11

    Topics: Autophagic Cell Death; Ciclopirox; Humans; Phosphorylation; Serine; STAT3 Transcription Factor; Stom

2022
Ciclopirox drives growth arrest and autophagic cell death through STAT3 in gastric cancer cells.
    Cell death & disease, 2022, 11-28, Volume: 13, Issue:11

    Topics: Autophagic Cell Death; Ciclopirox; Humans; Phosphorylation; Serine; STAT3 Transcription Factor; Stom

2022
Ciclopirox drives growth arrest and autophagic cell death through STAT3 in gastric cancer cells.
    Cell death & disease, 2022, 11-28, Volume: 13, Issue:11

    Topics: Autophagic Cell Death; Ciclopirox; Humans; Phosphorylation; Serine; STAT3 Transcription Factor; Stom

2022